To date, there are two different levers in play under Trump’s “Most Favored Nation”, 1. A drug...
Read moreFor decades, the free market model of the US healthcare system has been very attractive for biotech ...
Read moreWe've prepared an analysis of the top 10 most expensive drugs in the US compared with Germany, in th...
Read moreAmylyx has set the annual price of the ALS drug to $158,000, whereas ICER have suggested the drug sh...
Read moreAn affordable and sustainable market access landscape is key to ensure patient access to life-saving...
Read moreThis study investigates costs of gene/acute therapies versus chronic treatments for rare diseases, o...
Read more